Search by Drug Name or NDC
NDC 62135-0700-90 Amoxapine 25 mg/1 Details
Amoxapine 25 mg/1
Amoxapine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is AMOXAPINE.
Product Information
NDC | 62135-0700 |
---|---|
Product ID | 62135-700_04de67ce-c87b-d4bd-e063-6294a90a4392 |
Associated GPIs | |
GCN Sequence Number | 046083 |
GCN Sequence Number Description | amoxapine TABLET 25 MG ORAL |
HIC3 | H2U |
HIC3 Description | TRICYCLIC ANTIDEPRESSANTS,REL.NON-SEL.REUPT-INHIB |
GCN | 16559 |
HICL Sequence Number | 001648 |
HICL Sequence Number Description | AMOXAPINE |
Brand/Generic | Generic |
Proprietary Name | Amoxapine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Amoxapine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/1 |
Substance Name | AMOXAPINE |
Labeler Name | Chartwell RX, LLC |
Pharmaceutical Class | Tricyclic Antidepressant [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA072943 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0700-90 (62135070090)
NDC Package Code | 62135-700-90 |
---|---|
Billing NDC | 62135070090 |
Package | 90 TABLET in 1 BOTTLE (62135-700-90) |
Marketing Start Date | 2023-09-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |